Literature DB >> 8174084

Double target in situ hybridization applied to the study of numerical aberrations in childhood acute lymphoblastic leukemia.

S Tosi1, J Ritterbach, O Maglia, J Harbott, H Riehm, G Masera, A Biondi, F Lampert.   

Abstract

To test the feasibility of using fluorescent in situ hybridization (FISH) on interphase and metaphase cells to detect numerical aberrations in childhood acute lymphoblastic leukemia (ALL), we analyzed bone marrow of 15 patients with cytogenetically documented hyperdiploidy with more than 50 chromosomes at diagnosis. Patients were selected on the basis of being trisomic or tetrasomic for chromosomes 17 and/or 18 as determined by G-banded chromosome analysis. We performed a double target FISH using DNA probes specific for the centromeric region of chromosomes 17 and 18, respectively. The numerical changes regarding chromosome 17 and/or 18 identified by FISH on metaphases were found in all cases analyzed by FISH on interphase nuclei. In 8 of 15 patients, FISH on interphase nuclei demonstrated the presence of one or more groups of cells with different combinations of trisomy and tetrasomy of the two chromosomes investigated, beside the ones detected on metaphases. Overall our findings indicate that interphase FISH analysis could be a useful method to detect the presence of numerical aberrations of two chromosomes simultaneously in bone marrow and peripheral blood specimens of ALL as an adjunct to conventional cytogenetic investigation or metaphase FISH.

Entities:  

Mesh:

Year:  1994        PMID: 8174084     DOI: 10.1016/0165-4608(94)90193-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  1 in total

1.  Genomic imbalances are confined to non-proliferating cells in paediatric patients with acute myeloid leukaemia and a normal or incomplete karyotype.

Authors:  Erica Ballabio; Regina Regan; Elisa Garimberti; Jochen Harbott; Jutta Bradtke; Andrea Teigler-Schlegel; Andrea Biondi; Giovanni Cazzaniga; Giovanni Giudici; James S Wainscoat; Jacqueline Boultwood; Joanna M Bridger; Samantha J L Knight; Sabrina Tosi
Journal:  PLoS One       Date:  2011-06-09       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.